Intercure Ltd INCR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.85
- Day Range
- $0.87–0.90
- 52-Week Range
- $0.68–1.77
- Bid/Ask
- $0.60 / $1.28
- Shares Outstanding
- 54.68M
- Market Cap
- $47.63M
- Volume/Avg
- 4,163 / 33,530
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.59
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 285
- Website
- https://www.intercure.co
Valuation
|
Metric
|
INCR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.37 |
Price/Sales | 0.59 |
Price/Cash Flow | — |
Price/Earnings
INCR
Financial Strength
|
Metric
|
INCR
|
|---|---|
Quick Ratio | 0.94 |
Current Ratio | 1.48 |
Interest Coverage | −1.32 |
Quick Ratio
INCR
Profitability
|
Metric
|
INCR
|
|---|---|
Return on Assets (Normalized) | −0.95% |
Return on Equity (Normalized) | −1.70% |
Return on Invested Capital (Normalized) | 1.36% |
Return on Assets
INCR
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| Bknlpmrv | Gfmzg | $68B | |||
| Haleon PLC ADR
HLN
| Zppmnjtm | Mpyrw | $40B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Nnrptbyrj | Xgdsxr | $39B | |||
| Zoetis Inc Class A
ZTS
| Dhrkygppmn | Mrl | $34B | |||
| Viatris Inc
VTRS
| Sgwxyzt | Jnbj | $19B | |||
| Elanco Animal Health Inc
ELAN
| Bzxdj | Ffgw | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Dmlcjdlv | Tmsb | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| Wspdmnbh | Rbw | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| Wdtngpx | Smdjff | $2B | |||
| Perrigo Co PLC
PRGO
| Lcbncqvt | Nqwg | $2B |
United States